MGI Tech Hands with Lincoln University to Revolutionize New Zealand Viticulture with Genomics
AUCKLAND, New Zealand, Aug. 4, 2025 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company dedicated to developing core tools and technologies that drive innovation in life sciences, has joined efforts with Lincoln University in Canterbury to address sustainable challenges in viticulture through advanced sequencing technology. The initiative aims to utilize genomics...
Avio Health Launches AI Platform to Turn Disconnected Health Data into Preventive Intelligence
How Avio Health Is Rewiring Medicine for the Age of AI PALO ALTO, Calif. , July 15, 2025 /PRNewswire/ -- Today, Avio Health announced the launch of its proprietary clinical AI platform, which is designed to unify health data and support the shift toward preventative, personalized care. By integrating lab results, wearable data, genomics, imaging, and patient histories, the platform...
Argon Medical Expands Oncology Product Offering with Acquisition of the SeQure® and DraKon™ Microcatheters
PLANO, Texas, Jan. 14, 2025 /PRNewswire/ -- Argon Medical, a leading provider of medical device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Oncology procedures, announces the acquisition of certain assets of Accurate Medical Therapeutics, Ltd., the manufacturer and distributor of the SeQure® and DraKon™ microcatheters, from Guerbet SA, a...
KEENON Robotics Signed Strategic Partnership with SGP, Marked Official Entry into Senior Living and Healthcare Industries in Canada
TORONTO, Nov. 10, 2022 /PRNewswire/ -- KEENON Robotics ("KEENON"), a leading global intelligent service robotic company, has officially announced the new partnership with SGP Purchasing Partner Network (SGP) in Canada. KEENON has become SGP's exclusive vendor of commercial service robots since September 2022. KEENON ROBOTICS X SGP COOPERATION To date, KEENON has...
Japan Global Innovators’ Forum 2025
The annual meeting is returning for its second year after a successful inaugural event in 2024 TOKYO, Dec. 26, 2024 /PRNewswire/ -- Tokyo-based global media agency Pacific Bridge Media and Consulting Inc. (PBMC) is pleased to announce that the 2nd annual Japan Global Innovators' Forum (JGIF) will be held in March 2025. PBMC's solutions-focused multilingual news service J-Stories will...
Fresh2 Group Ltd. Announces Nasdaq Ticker Symbol Change from ‘ANPC’ to ‘FRES’
Ticker symbol change effective at the market open May 22, 2023 NEW YORK, May 20, 2023 /PRNewswire/ -- Fresh2 Group Ltd., formerly AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC), a company with operations in the United States and China focused on early cancer screening and detection and plans to enter into the operation of a business-to-business e-commerce food platform focused on the sale of Asian...
Aloe Vera of America Receives Award for Environmental Health Efforts
For the eighth consecutive year, the aloe vera product manufacturer and distributor was given the Blue Thumb Award DALLAS, Dec. 6, 2022 /PRNewswire/ -- Aloe Vera of America, Inc. the Dallas-based manufacturer and distributor of Forever Living's aloe vera-based products to over 160 countries, recently received the Blue Thumb Award for its continued commitment to environmental compliance. ...
Select the Right Medical-Grade TPU：ICP DAS – BMP Launches a New TPU Series at COMPAMED & IPF Japan 2023
HSINCHU, Oct. 31, 2023 /PRNewswire/ -- ICP DAS – Biomedical Polymers, Asia's first medical-grade TPU (thermoplastic polyurethane) manufacturer and supplier, will be exhibiting at COMPAMED in Germany and IPF in Japan in November and December 2023. The company proudly presents its new Arothane™ ARP-W series loaded with 30-80% Tungsten as the...
Yuyu Pharma Announces Strategic Investment in Dalan Animal Health as Part of Accelerated Global Expansion in Animal Health
SEOUL, South Korea, Dec. 2, 2025 /PRNewswire/ -- Yuyu Pharma announced today that it has completed a strategic investment in Dalan Animal Health, a U.S.-based biotechnology company advancing an innate immunity–based platform for developing vaccines for honeybees and shrimp. The investment marks a significant step in Yuyu Pharma's plan to become a...
Asieris Unveiled Results of Its Phase III Clinical Study for APL-1706, an Imaging Drug for Diagnosis or Surgery of Bladder Cancer, at the SIU 2023 Congress
SHANGHAI, Oct. 12, 2023 /PRNewswire/ -- Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, has unveiled its phase III clinical trial data for APL-1706 (Hexvix®), an imaging drug used for the diagnosis or surgery of bladder cancer, at the 43rd...
